Hyong Kim

Photo of Hyong Kim
Title(s)Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Clinical Trials

    Collapse Featured Content 

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A non-viral path to efficient and safe prime editing in vivo. Nat Nanotechnol. 2026 Jul; 21(7):914-915. Han Y, Kim HH. PMID: 42410217.
      View in: PubMed   Mentions:    Fields:    
    2. Adapting prime editing with split prime editors in Escherichia coli and its application to Staphylococcus aureus genome editing. Appl Microbiol Biotechnol. 2026 Jun 04. Ma SH, Yu G, Park S, Sung H, Jeong UJ, Kim HH, Cho J, Yoon SS. PMID: 42240651.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    3. Highly efficient and scarless genome editing via essential-gene-coupled homology-directed repair. Genome Res. 2026 06 01; 36(6):1187-1198. Yeo JH, Kim HH, Oh SH, Lee J. PMID: 41985988.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Publisher Correction: High-resolution functional mapping of androgen receptor variants. Nat Biomed Eng. 2026 Apr 27. Oh HC, Chang Y, Park J, Cheong Y, Lee KS, Han H, Kim HH. PMID: 42045674.
      View in: PubMed   Mentions:    Fields:    
    5. High-resolution functional mapping of androgen receptor variants. Nat Biomed Eng. 2026 Apr 06. Oh HC, Chang Y, Park J, Cheong Y, Lee KS, Han H, Kim HH. PMID: 41942549.
      View in: PubMed   Mentions:    Fields:    
    6. Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus. Nat Commun. 2026 Feb 06; 17(1). Kang CW, Hong ZY, Oh JH, Farh ME, Wang EK, Lee S, Kang UH, Nam JH, Lee YJ, Shin H, Kim YB, Jeon H, Jeong JW, Kim D, Kim JS, Hong SS, Park JP, Cho HJ, Fang S, Kim HH, Cho A, Lim BK, Sohn I, Ku CR. PMID: 41651859; PMCID: PMC12988217.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    7. A comprehensive functional atlas of ALK kinase domain variants reveals resistance landscape to ALK inhibitors. Genome Biol. 2026 Feb 03; 27(1). Oh HC, Han Y, Chang Y, Kim HH. PMID: 41630044; PMCID: PMC12958575.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. High-throughput evaluation of in vitro CRISPR activities enables optimized large-scale multiplex enrichment of rare variants. Nat Biomed Eng. 2026 Jul; 10(7):1410-1430. Yeo JH, Lee S, Kim S, Min JG, Gopalappa R, Oh HC, Kim HK, Nam EJ, Kim HH. PMID: 41168295.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    9. Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editing. Nat Biomed Eng. 2026 Jul; 10(7):1392-1409. Jung Y, Yu G, Oh HC, Lee JH, Jeon E, Bae J, Sim T, Kim HH. PMID: 41125871.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    10. Engineered virus-like particle-assembled Vegfa-targeting Cas9 ribonucleoprotein treatment alleviates neovascularization in wet age-related macular degeneration. Genome Biol. 2025 Oct 09; 26(1):346. Wu J, Jang H, Kwak H, Son M, Jiang W, Hwang HY, Jo DH, Kim D, Kim HH, Kim JH. PMID: 41068986; PMCID: PMC12509411.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    11. Engineered virus-like particles for in vivo gene editing ameliorate hearing loss in murine DFNA2 model. Mol Ther. 2025 Dec 03; 33(12):6449-6462. Noh B, Gopalappa R, Lin H, Gee HY, Choi JY, Kim HH, Jung J. PMID: 40898619; PMCID: PMC12703167.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    12. Functional assessment of all ATM SNVs using prime editing and deep learning. Cell. 2025 Sep 04; 188(18):5081-5099.e27. Lee KS, Min JG, Cheong Y, Oh HC, Jung SY, Park JI, Song M, Seo JH, Cho SR, Kim HH. PMID: 40580951.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. A rational engineering strategy for structural dynamics modulation enables target specificity enhancement of the Cas9 nuclease. Nucleic Acids Res. 2025 Jun 20; 53(12). Sung K, Jung Y, Kim N, Kim YW, Kim HH, Kim SK, Bae S. PMID: 40539512; PMCID: PMC12204706.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Intravitreal adenine base editing of RS1 improves vision in a preclinical mouse model of retinoschisis. Mol Ther. 2025 Aug 06; 33(8):3955-3967. Jo DH, Jang H, Cho CS, Lee SJ, Heo JH, Kim JA, Kim SJ, Ryu W, Park CW, Kang BC, Gee HY, Sung YH, Kim HH, Kim JH. PMID: 40253584; PMCID: PMC12461659.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    15. Saturation profiling of drug-resistant genetic variants using prime editing. Nat Biotechnol. 2025 Sep; 43(9):1471-1484. Kim Y, Oh HC, Lee S, Kim HH. PMID: 39533107.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    16. SynDesign: web-based prime editing guide RNA design and evaluation tool for saturation genome editing. Nucleic Acids Res. 2024 07 05; 52(W1):W121-W125. Park J, Yu G, Seo SY, Yang J, Kim HH. PMID: 38682594; PMCID: PMC11223855.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. In vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model. Mol Ther. 2024 07 03; 32(7):2190-2206. Gopalappa R, Lee M, Kim G, Jung ES, Lee H, Hwang HY, Lee JG, Kim SJ, Yoo HJ, Sung YH, Kim D, Baek IJ, Kim HH. PMID: 38796705; PMCID: PMC11286820.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    18. Author Correction: Predicting the efficiency of prime editing guide RNAs in human cells. Nat Biotechnol. 2024 Mar; 42(3):529. Kim HK, Yu G, Park J, Min S, Lee S, Yoon S, Kim HH. PMID: 38332117.
      View in: PubMed   Mentions:    Fields:    
    19. Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies. Pulm Ther. 2024 Mar; 10(1):85-107. Kim NH, Chin KM, McLaughlin VV, DuBrock H, Restrepo-Jaramillo R, Safdar Z, MacDonald G, Martin N, Rosenberg D, Solonets M, Channick R. PMID: 38184507; PMCID: PMC10881949.
      View in: PubMed   Mentions: 6  
    20. Deep learning models to predict the editing efficiencies and outcomes of diverse base editors. Nat Biotechnol. 2024 Mar; 42(3):484-497. Kim N, Choi S, Kim S, Song M, Seo JH, Min S, Park J, Cho SR, Kim HH. PMID: 37188916.
      View in: PubMed   Mentions: 38     Fields:    
    21. Massively parallel evaluation and computational prediction of the activities and specificities of 17 small Cas9s. Nat Methods. 2023 07; 20(7):999-1009. Seo SY, Min S, Lee S, Seo JH, Park J, Kim HK, Song M, Baek D, Cho SR, Kim HH. PMID: 37188955.
      View in: PubMed   Mentions: 8     Fields:    
    22. Prediction of efficiencies for diverse prime editing systems in multiple cell types. Cell. 2023 05 11; 186(10):2256-2272.e23. Yu G, Kim HK, Park J, Kwak H, Cheong Y, Kim D, Kim J, Kim J, Kim HH. PMID: 37119812.
      View in: PubMed   Mentions: 75     Fields:    
    23. DNA double-strand break-free CRISPR interference delays Huntington's disease progression in mice. Commun Biol. 2023 04 28; 6(1):466. Seo JH, Shin JH, Lee J, Kim D, Hwang HY, Nam BG, Lee J, Kim HH, Cho SR. PMID: 37117485; PMCID: PMC10147674.
      View in: PubMed   Mentions: 12  Translation:HumansAnimalsCells
    24. Sniper2L is a high-fidelity Cas9 variant with high activity. Nat Chem Biol. 2023 08; 19(8):972-980. Kim YH, Kim N, Okafor I, Choi S, Min S, Lee J, Bae SM, Choi K, Choi J, Harihar V, Kim Y, Kim JS, Kleinstiver BP, Lee JK, Ha T, Kim HH. PMID: 36894722; PMCID: PMC10374439.
      View in: PubMed   Mentions: 30     Fields:    
    25. Adherens junctions organize size-selective proteolytic hotspots critical for Notch signalling. Nat Cell Biol. 2022 12; 24(12):1739-1753. Kwak M, Southard KM, Kim WR, Lin A, Kim NH, Gopalappa R, Lee HJ, An M, Choi SH, Jung Y, Noh K, Farlow J, Georgakopoulos A, Robakis NK, Kang MK, Kutys ML, Seo D, Kim HH, Kim YH, Cheon J, Gartner ZJ, Jun YW. PMID: 36456828; PMCID: PMC10665132.
      View in: PubMed   Mentions: 11     Fields:    
    26. In vivo application of base and prime editing to treat inherited retinal diseases. Prog Retin Eye Res. 2023 05; 94:101132. Jo DH, Bae S, Kim HH, Kim JS, Kim JH. PMID: 36241547.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    27. Magnetogenetics with Piezo1 Mechanosensitive Ion Channel for CRISPR Gene Editing. Nano Lett. 2022 09 28; 22(18):7415-7422. Shin W, Jeong S, Lee JU, Jeong SY, Shin J, Kim HH, Cheon J, Lee JH. PMID: 36069378.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    28. High-throughput functional evaluation of human cancer-associated mutations using base editors. Nat Biotechnol. 2022 06; 40(6):874-884. Kim Y, Lee S, Cho S, Park J, Chae D, Park T, Minna JD, Kim HH. PMID: 35411116; PMCID: PMC10243181.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    29. In vivo outer hair cell gene editing ameliorates progressive hearing loss in dominant-negative Kcnq4 murine model. Theranostics. 2022; 12(5):2465-2482. Noh B, Rim JH, Gopalappa R, Lin H, Kim KM, Kang MJ, Gee HY, Choi JY, Kim HH, Jung J. PMID: 35265220; PMCID: PMC8899569.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    30. Basic Principles and Clinical Applications of CRISPR-Based Genome Editing. Yonsei Med J. 2022 Feb; 63(2):105-113. Lim JM, Kim HH. PMID: 35083895; PMCID: PMC8819410.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    31. Improving CRISPR tools by elucidating DNA repair. Nat Biotechnol. 2021 12; 39(12):1512-1514. Lim JM, Kim HH. PMID: 34873327.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    32. Generation of a more efficient prime editor 2 by addition of the Rad51 DNA-binding domain. Nat Commun. 2021 09 23; 12(1):5617. Song M, Lim JM, Min S, Oh JS, Kim DY, Woo JS, Nishimasu H, Cho SR, Yoon S, Kim HH. PMID: 34556671; PMCID: PMC8460726.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    33. Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases. Nat Biomed Eng. 2022 02; 6(2):181-194. Jang H, Jo DH, Cho CS, Shin JH, Seo JH, Yu G, Gopalappa R, Kim D, Cho SR, Kim JH, Kim HH. PMID: 34446856.
      View in: PubMed   Mentions: 117     Fields:    Translation:Animals
    34. Recording of elapsed time and temporal information about biological events using Cas9. Cell. 2021 Feb 18; 184(4):1047-1063.e23. Park J, Lim JM, Jung I, Heo SJ, Park J, Chang Y, Kim HK, Jung D, Yu JH, Min S, Yoon S, Cho SR, Park T, Kim HH. PMID: 33539780.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    35. Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE. J Heart Lung Transplant. 2021 04; 40(4):279-288. Kim NH, Hemnes AR, Chakinala MM, Highland KB, Chin KM, McLaughlin V, Zhao C, Narayan V, Farber HW. PMID: 33526303.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    36. An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer. Nat Commun. 2021 01 08; 12(1):183. Kim J, Park K, Kim MJ, Lim H, Kim KH, Kim SW, Lee ES, Kim HH, Kim SJ, Hur KY, Kim JH, Ahn JH, Yoon KH, Kim JW, Lee MS. PMID: 33420039; PMCID: PMC7794419.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    37. Predicting the efficiency of prime editing guide RNAs in human cells. Nat Biotechnol. 2021 02; 39(2):198-206. Kim HK, Yu G, Park J, Min S, Lee S, Yoon S, Kim HH. PMID: 32958957.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansCells
    38. Chemical Controllable Gene Drive in Drosophila. ACS Synth Biol. 2020 Sep 18; 9(9):2362-2377. Chae D, Lee J, Lee N, Park K, Moon SJ, Kim HH. PMID: 32786353.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    39. Sequence-specific prediction of the efficiencies of adenine and cytosine base editors. Nat Biotechnol. 2020 09; 38(9):1037-1043. Song M, Kim HK, Lee S, Kim Y, Seo SY, Park J, Choi JW, Jang H, Shin JH, Min S, Quan Z, Kim JH, Kang HC, Yoon S, Kim HH. PMID: 32632303.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    40. Prediction of the sequence-specific cleavage activity of Cas9 variants. Nat Biotechnol. 2020 11; 38(11):1328-1336. Kim N, Kim HK, Lee S, Seo JH, Choi JW, Park J, Min S, Yoon S, Cho SR, Kim HH. PMID: 32514125.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansCells
    41. Genome-scale screening of deubiquitinase subfamily identifies USP3 as a stabilizer of Cdc25A regulating cell cycle in cancer. Cell Death Differ. 2020 11; 27(11):3004-3020. Das S, Chandrasekaran AP, Suresh B, Haq S, Kang JH, Lee SJ, Kim J, Kim J, Lee S, Kim HH, Kim KS, Ramakrishna S. PMID: 32415280; PMCID: PMC7566649.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    42. High-throughput analysis of the activities of xCas9, SpCas9-NG and SpCas9 at matched and mismatched target sequences in human cells. Nat Biomed Eng. 2020 01; 4(1):111-124. Kim HK, Lee S, Kim Y, Park J, Min S, Choi JW, Huang TP, Yoon S, Liu DR, Kim HH. PMID: 31937939.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCells
    43. SpCas9 activity prediction by DeepSpCas9, a deep learning-based model with high generalization performance. Sci Adv. 2019 11; 5(11):eaax9249. Kim HK, Kim Y, Lee S, Min S, Bae JY, Choi JW, Park J, Jung D, Yoon S, Kim HH. PMID: 31723604; PMCID: PMC6834390.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    44. Programmable Nuclease-Based Integration into Novel Extragenic Genomic Safe Harbor Identified from Korean Population-Based CNV Analysis. Mol Ther Oncolytics. 2019 Sep 27; 14:253-265. Lee ES, Moon S, Abu-Bonsrah KD, Kim YK, Hwang MY, Kim YJ, Kim S, Hwang NS, Kim HH, Kim BJ. PMID: 31463366; PMCID: PMC6708990.
      View in: PubMed   Mentions: 1  
    45. En bloc and segmental deletions of human XIST reveal X chromosome inactivation-involving RNA elements. Nucleic Acids Res. 2019 05 07; 47(8):3875-3887. Lee HJ, Gopalappa R, Sunwoo H, Choi SW, Ramakrishna S, Lee JT, Kim HH, Nam JW. PMID: 30783652; PMCID: PMC6486550.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    46. Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption. Nucleic Acids Res. 2018 07 06; 46(12):e71. Gopalappa R, Suresh B, Ramakrishna S, Kim HH. PMID: 29584876; PMCID: PMC6158698.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    47. Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical Dyslamination. Neuron. 2018 07 11; 99(1):83-97.e7. Park SM, Lim JS, Ramakrishina S, Kim SH, Kim WK, Lee J, Kang HC, Reiter JF, Kim DS, Kim HH, Lee JH. PMID: 29937275.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansAnimalsCells
    48. In vivo gene correction with targeted sequence substitution through microhomology-mediated end joining. Biochem Biophys Res Commun. 2018 07 07; 502(1):116-122. Shin JH, Jung S, Ramakrishna S, Kim HH, Lee J. PMID: 29787760.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    49. Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth. Genome Res. 2018 Mar 01; 28(3):374-382. Kim W, Lee S, Kim HS, Song M, Cha YH, Kim YH, Shin J, Lee ES, Joo Y, Song JJ, Choi EJ, Choi JW, Lee J, Kang M, Yook JI, Lee MG, Kim YS, Paik S, Kim HH. PMID: 29326299; PMCID: PMC5848616.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    50. Deep learning improves prediction of CRISPR-Cpf1 guide RNA activity. Nat Biotechnol. 2018 Mar; 36(3):239-241. Kim HK, Min S, Song M, Jung S, Choi JW, Kim Y, Lee S, Yoon S, Kim HH. PMID: 29431740.
      View in: PubMed   Mentions: 192     Fields:    Translation:Cells
    51. RanBPM: a potential therapeutic target for modulating diverse physiological disorders. Drug Discov Today. 2017 12; 22(12):1816-1824. Das S, Suresh B, Kim HH, Ramakrishna S. PMID: 28847759.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    52. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia. Am J Hum Genet. 2017 Mar 02; 100(3):454-472. Lim JS, Gopalappa R, Kim SH, Ramakrishna S, Lee M, Kim WI, Kim J, Park SM, Lee J, Oh JH, Kim HD, Park CH, Lee JS, Kim S, Kim DS, Han JM, Kang HC, Kim HH, Lee JH. PMID: 28215400; PMCID: PMC5339289.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansAnimalsCells
    53. Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction. Stem Cells Transl Med. 2017 03; 6(3):1040-1051. Cho HM, Kim PH, Chang HK, Shen YM, Bonsra K, Kang BJ, Yum SY, Kim JH, Lee SY, Choi MC, Kim HH, Jang G, Cho JY. PMID: 28186692; PMCID: PMC5442764.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    54. Astroglial Activation by an Enriched Environment after Transplantation of Mesenchymal Stem Cells Enhances Angiogenesis after Hypoxic-Ischemic Brain Injury. Int J Mol Sci. 2016 Sep 14; 17(9). Cho SR, Suh H, Yu JH, Kim HH, Seo JH, Seo CH. PMID: 27649153; PMCID: PMC5037823.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    55. Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment. Cardiol Clin. 2016 Aug; 34(3):435-41. Kim NH. PMID: 27443139.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    56. Concise Review: Fate Determination of Stem Cells by Deubiquitinating Enzymes. Stem Cells. 2017 01; 35(1):9-16. Chandrasekaran AP, Suresh B, Kim HH, Kim KS, Ramakrishna S. PMID: 27341175.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    57. In Situ Pluripotency Factor Expression Promotes Functional Recovery From Cerebral Ischemia. Mol Ther. 2016 09; 24(9):1538-49. Seo JH, Lee MY, Yu JH, Kim MS, Song M, Seo CH, Kim HH, Cho SR. PMID: 27455881; PMCID: PMC5113101.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    58. Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape. Eur Respir Rev. 2015 Jun; 24(136):173-7. Kim NH, Mayer E. PMID: 26028629; PMCID: PMC9487821.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    59. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D92-9. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. PMID: 24355646.
      View in: PubMed   Mentions: 179     Fields:    Translation:HumansAnimals
    60. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2012 Mar 01; 21(123):27-31. Kim NH, Lang IM. PMID: 22379171; PMCID: PMC9487479.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    61. Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension? Eur Respir Rev. 2010 Mar; 19(115):68-71. Kim NH. PMID: 20956169; PMCID: PMC9491640.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    62. Assessment of operability in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006 Sep; 3(7):584-8. Kim NH. PMID: 16963538.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    63. Diagnosis and evaluation of the patient with pulmonary hypertension. Cardiol Clin. 2004 Aug; 22(3):367-73, v-vi. Kim NH. PMID: 15302357.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Hyong's Networks
    Concepts (266)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California